Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma
Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma
Recruiting · NCT05260619 · Registry updated 2022-03-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma | primary central nervous system lymphoma | Recruiting | Phase 2 | 2022-03-02 | NCT05260619 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Samyang BioPharm | 1 |
| Seoul National University Bundang Hospital | 114 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Seoul National University Bundang Hospital | Seongnam-si | South Korea | 1 |